Browsing: Health

Researchers at Michigan State University have developed a temperature-responsive gel designed to help chemotherapy patients retain their hair during treatment. The gel, which functions similarly to shampoo in application, was tested in preclinical studies and significantly reduced hair loss by

A North Carolina-based pet food manufacturer has issued a voluntary recall of several raw dog and cat food products following the detection of Salmonella and Listeria monocytogenes, prompting a nationwide health alert for pet owners and retailers. The recall, announced

A new peer-reviewed study has found that insufficient daily water intake may significantly heighten the body’s hormonal stress response, even in the absence of thirst or subjective signs of dehydration. Conducted by researchers at Liverpool John Moores University and published

Novo Nordisk has announced a major pricing shift for its diabetes drug Ozempic, offering it directly to U.S. patients without insurance for $499 per month. The new out-of-pocket price cuts the drug’s list cost by more than 50 percent and

New clinical guidelines released today by the American Heart Association and the American College of Cardiology recommend initiating treatment for high blood pressure earlier and call for a complete halt to alcohol consumption to reduce cardiovascular and cognitive health risks.

Health authorities in Florida are investigating a foodborne illness outbreak linked to raw milk from an unnamed farm that has resulted in 21 confirmed cases of infection. According to the Florida Department of Health, patients have contracted Campylobacter and Shiga

The U.S. Food and Drug Administration (FDA) has elevated the recall classification for 64,800 pounds of Bunge North America Inc.’s European Style Butter Blend to a Class II level, signaling a higher risk of potential health consequences. The recall, originally

A new study has identified a potential link between the artificial sweetener sucralose and reduced effectiveness of cancer immunotherapy treatments in patients with melanoma and non-small cell lung cancer. The research, conducted by the University of Pittsburgh in collaboration with

The European Medicines Agency (EMA) has issued a positive recommendation for the authorization of lenacapavir, a twice-yearly injectable medication for HIV prevention. Marketed in Europe under the name Yeytuo by Gilead Sciences, the drug is now positioned for formal approval

A newly published study led by researchers at Mount Sinai has identified a significant association between exposure to per- and polyfluoroalkyl substances (PFAS) and an increased risk of developing type 2 diabetes. The findings, released in the peer-reviewed journal eBioMedicine,